Introduction Obesity is frequently a comorbidity of type 2 diabetes. Even modest weight loss
can significantly improve glucose homeostasis and lessen cardiometabolic risk factors in …

The majority of patients with type 2 diabetes mellitus are overweight or obese at the time of
diagnosis, and obesity is a recognised risk factor for type 2 diabetes and coronary heart …

Obesity is a complex metabolic condition that can have a negative impact on one's health
and even result in mortality. The management of obesity has been addressed in a number of …

Tight diabetes control sometimes comes with a price: weight gain and hypoglycemia. Two of
the three major recent trials that looked at the relationship between intensive diabetes …

Diabetes is a growing global health concern, as is obesity. Diabetes and obesity are
intrinsically linked: obesity increases the risk of diabetes and also contributes to disease …

We are facing a global epidemic of obesity and type 2 diabetes. Weight loss, in the context of
obesity and type 2 diabetes, may improve glycaemic control and weight‐related …

Context: The close link between type 2 diabetes and excess body weight highlights the need
to consider the weight effects of different treatment regimens. We examine the impact of …

Two landmark intervention studies, the Diabetes Control and Complications Trial (DCCT) in
patients with type 1 diabetes mellitus and the United Kingdom Prospective Diabetes Study …

Objective Sodium glucose cotransporter 2 (SGLT2) inhibitors may induce urinary glucose
excretion via the inhibition of renal glucose reabsorption, improve glycemic control, and …

Background: The majority of patients with type 2 diabetes mellitus (T2DM) are overweight or
obese. Obesity is a significant risk factor for increased morbidity and mortality in people with …